Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Boyer

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Translational Vision Science & Technology|March 28, 2023
Sustained Ocular Delivery of Bevacizumab Using Densomeres in Rabbits: Effects on Molecular Integrity and BioactivityJan S Peterson, WeiLiam Chen, Barry M Libin, et al.
Current Eye Research|July 21, 2004
Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathyMehryar Taban, Edgar L Thomas, David S Boyer, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Antisense oligonucleotide therapy in diabetic retinopathyPeter Hnik, David S Boyer, Lisa R Grillone, et al.
Ophthalmology|August 1, 2009
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degenerationDavid S Boyer, Jeffrey S Heier, David M Brown, et al.
Retina (Philadelphia, Pa.)|September 23, 2024
ReplyDavid S Boyer, Marion R Munk, Stephanie E Tedford, et al.
American Journal of Ophthalmology|October 18, 2002
Management of pupillary block glaucoma in phakic patients after vitrectomy with silicone oil injectionFelipe Navas, David S Boyer, Edgar L Thomas, et al.
International Journal of Retina and Vitreous|April 13, 2021
Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathyDavid S Boyer, Joerg F Rippmann, Michael S Ehrlich, et al.
American Journal of Ophthalmology|February 17, 2019
Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year OutcomesJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
American Journal of Ophthalmology|December 2, 2015
ReplyRobert B Bhisitkul, Thais S Mendes, Soraya Rofagha, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Translational Vision Science & Technology|March 28, 2023
Sustained Ocular Delivery of Bevacizumab Using Densomeres in Rabbits: Effects on Molecular Integrity and BioactivityJan S Peterson, WeiLiam Chen, Barry M Libin, et al.
Current Eye Research|July 21, 2004
Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathyMehryar Taban, Edgar L Thomas, David S Boyer, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Antisense oligonucleotide therapy in diabetic retinopathyPeter Hnik, David S Boyer, Lisa R Grillone, et al.
Ophthalmology|August 1, 2009
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degenerationDavid S Boyer, Jeffrey S Heier, David M Brown, et al.
Retina (Philadelphia, Pa.)|September 23, 2024
ReplyDavid S Boyer, Marion R Munk, Stephanie E Tedford, et al.
American Journal of Ophthalmology|October 18, 2002
Management of pupillary block glaucoma in phakic patients after vitrectomy with silicone oil injectionFelipe Navas, David S Boyer, Edgar L Thomas, et al.
International Journal of Retina and Vitreous|April 13, 2021
Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathyDavid S Boyer, Joerg F Rippmann, Michael S Ehrlich, et al.
American Journal of Ophthalmology|February 17, 2019
Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year OutcomesJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
American Journal of Ophthalmology|December 2, 2015
ReplyRobert B Bhisitkul, Thais S Mendes, Soraya Rofagha, et al.
Pageof 14